Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) were down 3.9% during trading on Monday after an insider sold shares in the company. The company traded as low as $18.64 and last traded at $18.64. Approximately 9,380 shares traded hands during trading, a decline of 94% from the average daily volume of 144,773 […]
Related Keywords
Rahuld Ballal , , Highvista Strategies , Northern Trust Corp , Blackrock Inc , Nasdaq , Partners Vi Llc , Geode Capital Management , Enliven Therapeutics Inc , Enliven Therapeutics , Get Free Report , Director Rahul , Street Corp , Capital Management , Trust Corp , Enliven Therapeutics Daily , Nasdaq Elvn , Elvn , Medical , Stocks , Technicals ,
comparemela.com © 2020. All Rights Reserved.